Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID‐19

Author:

Takayama Shin123ORCID,Kikuchi Akiko123,Makino Toshiaki4ORCID,Kainuma Mosaburo5ORCID,Namiki Takao6ORCID,Ito Takashi7

Affiliation:

1. Department of Kampo Medicine Tohoku University Hospital Sendai Japan

2. Department of Education and Support for Regional Medicine Tohoku University Hospital Sendai Japan

3. Department of Kampo and Integrative Medicine Tohoku University Graduate School of Medicine Sendai Japan

4. Department of Pharmacognosy Graduate School of Pharmaceutical Sciences, Nagoya City University Nagoya Japan

5. Community Medicine Education Unit Graduate School of Medical Science, Kyushu University Fukuoka Japan

6. Department of Japanese‐Oriental (Kampo) Medicine Graduate School of Medicine, Chiba University Chiba Japan

7. Akashi Clinic Kanda Tokyo Japan

Publisher

Wiley

Reference104 articles.

1. The Novel Coronavirus Originating in Wuhan, China

2. Clinical observation of Qingfeipaidu decoction in the treatment of COVID‐19;Wang R;Pharmacol. Clin. Chin. Materia Medica.,2020

3. Retrospektive auf die Prävention und Therapie von Covid-19 mit Chinesischer Medizin in China

4. Pharmaceutical and Medical Device Regulatory Science Society of Japan.Japanese Pharmacopoeia Seventeenth Edition (JP XVII) Tokyo: Jiho 2016.

5. ISO/TR23022:2018.Traditional Chinese medicine — Controlled vocabulary index on Japanese Kampo formulas and indication codes for products Geneva Switzerland. International Organization for Standardization 2018.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3